Verition Fund Management LLC Altimmune, Inc. Transaction History

Verition Fund Management LLC

  • $23.6 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$4.19 - $16.83 $254,152 - $1.02 Million
60,657 New
60,657 $255,000
Q4 2020

Feb 16, 2021
SELL
$7.84 - $14.22 $565,585 - $1.03 Million
-72,141 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$9.93 - $33.26 $716,360 - $2.4 Million
72,141 New
72,141 $952,000

Others Institutions Holding ALT

# of Institutions
208
Shares Held
39.5M
Call Options Held
1.94M
Put Options Held
1.38M
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $315M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email